Cannabix Technologies (OTCMKTS:BLOZF – Get Free Report) announced its earnings results on Tuesday. The company reported ($0.01) earnings per share for the quarter, Zacks reports.
Cannabix Technologies Stock Performance
Shares of OTCMKTS BLOZF traded down $0.02 during midday trading on Tuesday, hitting $0.42. The company’s stock had a trading volume of 75,591 shares, compared to its average volume of 96,232. The firm has a market cap of $51.30 million, a P/E ratio of -21.19 and a beta of 0.65. The firm’s fifty day moving average price is $0.39 and its 200-day moving average price is $0.41. Cannabix Technologies has a 1-year low of $0.20 and a 1-year high of $0.50.
Cannabix Technologies Company Profile
Cannabix Technologies Inc is a Canada-based developer of biosensor technologies focused on the rapid, non-invasive detection of cannabis impairment. The company’s flagship product is a handheld breathalyzer device designed to identify recent use of tetrahydrocannabinol (THC) within minutes of exhalation, offering law enforcement agencies, public safety organizations and workplace safety departments a potential tool to assess impairment in real time.
The Cannabix breathalyzer employs proprietary sensor arrays and on-board algorithms to distinguish THC molecules in breath samples, delivering results without the need for laboratory analysis.
Read More
- Five stocks we like better than Cannabix Technologies
- Wall Street Stockpicker Names #1 Stock of 2026
- Do not delete, read immediately
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- A month before the crash
- Buy this $2 Gold Stock Before January 1, 2026
Receive News & Ratings for Cannabix Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannabix Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
